Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Isoform-specific modulation of pressure-stimulated cancer cell proliferation and adhesion by α-actinin.
Downey C, Craig DH, Basson MD.
Am J Surg. 2011 Nov;202(5):520-3. Epub 2011 Sep 9.
Related citations
Tumor deposits in colorectal cancer: a moving target.
Greene FL.
Ann Surg. 2012 Feb;255(2):214-5. No abstract available.
Prognostic Value of Number of Removed Lymph Nodes, Number of Involved Lymph Nodes, and Lymph Node Ratio in 7502 Breast Cancer Patients Enrolled onto Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Tausch C, Taucher S, Dubsky P, Seifert M, Reitsamer R, Kwasny W, Jakesz R, Fitzal F, Filipcic L, Fridrik M, Greil R, Gnant M.
Ann Surg Oncol. 2012 Jun;19(6):1808-17. Epub 2011 Dec 30.
Repeat Hepatectomy for Metastatic Colorectal Cancer Is Safe but Marginally Effective.
Jones NB, McNally ME, Malhotra L, Abdel-Misih S, Martin EW, Bloomston M, Schmidt CR.
Ann Surg Oncol. 2011 Dec 30. [Epub ahead of print]
Multi-center phase II study of FLOX for advanced colorectal cancer patients in Japan: SWIFT 3 study.
Kato T, Nagata N, Fujii M, Takemoto H, Kondo K, Okuyama Y, Tominaga H, Sakamoto J, Mishima H.
Anticancer Res. 2011 Dec;31(12):4657-64.
Comparison of lymphangiogenesis between primary colorectal cancer and corresponding liver metastases.
Schoppmann A, Tamandl D, Herberger B, Längle F, Birner P, Geleff S, Grünberger T, Schoppmann SF.
Anticancer Res. 2011 Dec;31(12):4605-11.
Impact of chemotherapy for colorectal cancer on regulatory T-cells and tumor immunity.
Maeda K, Hazama S, Tokuno K, Kan S, Maeda Y, Watanabe Y, Kamei R, Shindo Y, Maeda N, Yoshimura K, Yoshino S, Oka M.
Anticancer Res. 2011 Dec;31(12):4569-74.
Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation.
Coppedè F.
Cancer Lett. 2011 Dec 24. [Epub ahead of print]
Increasing potential of HER3 signaling in colon cancer progression and therapy.
Gespach C.
Clin Cancer Res. 2012 Feb 15;18(4):917-9. Epub 2011 Dec 28.
Biological function and prognostic significance of peroxisome proliferator-activated receptor δ in rectal cancer.
Yang L, Zhang H, Zhou ZG, Yan H, Adell G, Sun XF.
Clin Cancer Res. 2011 Jun 1;17(11):3760-70. Epub 2011 Apr 29.
The long-term gastrointestinal functional outcomes following curative anterior resection in adults with rectal cancer: a systematic review and meta-analysis.
Scheer AS, Boushey RP, Liang S, Doucette S, O'Connor AM, Moher D.
Dis Colon Rectum. 2011 Dec;54(12):1589-97. Review.
Single-port laparoscopic diverting sigmoid colostomy.
Nguyen HM, Causey MW, Steele SR, Maykel JA.
Dis Colon Rectum. 2011 Dec;54(12):1585-8.
Usefulness of an intensive bowel cleansing strategy for repeat colonoscopy after preparation failure.
Ibáñez M, Parra-Blanco A, Zaballa P, Jiménez A, Fernández-Velázquez R, Fernández-Sordo JO, González-Bernardo O, Rodrigo L.
Dis Colon Rectum. 2011 Dec;54(12):1578-84.
Different bowel preparation schedule leads to different diagnostic yield of proximal and nonpolypoid colorectal neoplasm at screening colonoscopy in average-risk population.
Chiu HM, Lin JT, Lee YC, Liang JT, Shun CT, Wang HP, Wu MS.
Dis Colon Rectum. 2011 Dec;54(12):1570-7.
Long-term follow-up features on rectal MRI during a wait-and-see approach after a clinical complete response in patients with rectal cancer treated with chemoradiotherapy.
Lambregts DM, Maas M, Bakers FC, Cappendijk VC, Lammering G, Beets GL, Beets-Tan RG.
Dis Colon Rectum. 2011 Dec;54(12):1521-8.
Intramural and mesorectal distal spread detected by whole-mount sections in the determination of optimal distal resection margin in patients undergoing surgery for rectosigmoid or rectal cancer without preoperative therapy.
Shimada Y, Takii Y, Maruyama S, Ohta T.
Dis Colon Rectum. 2011 Dec;54(12):1510-20.
The anatomical and surgical consequences of right colectomy for cancer.
Spasojevic M, Stimec BV, Gronvold LB, Nesgaard JM, Edwin B, Ignjatovic D.
Dis Colon Rectum. 2011 Dec;54(12):1503-9.
Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy.
Warrier SK, Trainer AH, Lynch AC, Mitchell C, Hiscock R, Sawyer S, Boussioutas A, Heriot AG.
Dis Colon Rectum. 2011 Dec;54(12):1480-7.
CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
Kawamura M, Toiyama Y, Tanaka K, Saigusa S, Okugawa Y, Hiro J, Uchida K, Mohri Y, Inoue Y, Kusunoki M.
Eur J Cancer. 2011 Dec 23. [Epub ahead of print]
Cdx2 controls expression of the protocadherin Mucdhl, an inhibitor of growth and β-catenin activity in colon cancer cells.
Hinkel I, Duluc I, Martin E, Guenot D, Freund JN, Gross I.
Gastroenterology. 2012 Apr;142(4):875-885.e3. Epub 2011 Dec 24.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on